The NMDA receptor subunit GluN2D is a potential target for rapid antidepressant action.
Vestring S, Veleanu M, Perez MC, Schuberth LE, Bronnec M, Li A, Würz LM, Erdogdu F, Stocker J, Moos J, Weigel D, Theiß A, Wendler E, Borger LM, Voita S, Heynicke F, Brandl J, Hummel F, Vivet C, Jocher D, Loewe P, Barmann S, Smoltczyk L, Zimmermann S, Prabhakaran P, Lokaj G, Sarrazin DH, Suarez G, Bernhardt J, du Vinage C, Grießbach E, Lais J, Gensch N, Wojtas M, Knafo S, Wendel J, Warneke J, Grohe JP, Günther S, Moumbock AFA, Domschke K, Serchov T, Bischofberger J, Normann C.
Vestring S, et al.
Nat Commun. 2025 Nov 26;16(1):10613. doi: 10.1038/s41467-025-66774-w.
Nat Commun. 2025.
PMID: 41298447
Free PMC article.
We use ketamine, the selective GluN2C/D inhibitor NAB-14, Grin2d-siRNA and chemogenetic approaches in hippocampal slices and in vivo mice. We find that GluN2D antagonism inhibits NMDAR currents in interneurons but not pyramidal cells, and that GluN2D-mediated recruitment o …
We use ketamine, the selective GluN2C/D inhibitor NAB-14, Grin2d-siRNA and chemogenetic approaches in hippocampal slices and in vivo …